Seven One Seven Capital Management Novavax Inc Transaction History

Seven One Seven Capital Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$8.86 - $25.04 $96,520 - $272,785	10,894 New	10,894 $111,000
Q2 2022 Aug 12, 2022	BUY	$36.28 - $75.29 $185,136 - $384,204	5,103 New	5,103 $262,000
Q1 2022 May 16, 2022	SELL	$69.73 - $142.9 $168,467 - $345,246	-2,416 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $54,900 - $88,931	408 Added 20.32%	2,416 $346,000
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $5,511 - $8,387	31 Added 1.57%	2,008 $416,000
Q2 2021 Aug 13, 2021	BUY	$121.0 - $257.67 $28,193 - $60,037	233 Added 13.36%	1,977 $420,000
Q1 2021 May 13, 2021	BUY	$112.98 - $319.93 $197,037 - $557,957	1,744 New	1,744 $316,000

286

84.7M

5.38M

8.62M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $718M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Seven One Seven Capital Management, based on Form 13F filings with the SEC.

Stay updated on Seven One Seven Capital Management with notifications on news.